Axsome COO awarded 8,669 performance stock units

Jacobson Mark L. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Jacobson Mark L. reported acquisition or exercise transactions in this Form 4 filing.

Axsome Therapeutics, Inc. reported that Chief Operating Officer Mark L. Jacobson received a grant of 8,669 Performance Stock Units (PSUs). Each PSU represents a contingent right to receive one share of Axsome common stock.

The PSUs will vest only if specified sales and commercial launch milestones are achieved and if Jacobson remains in service through each vesting date. Following this grant, he holds 8,669 PSUs directly as part of his equity-based compensation.

Insider Trade Summary

Grant/Award: 8,669 shares

Grant/Award 1 txn

Insider Jacobson Mark L.

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Performance Stock Units	8,669	$0.00	$0.00

Holdings After Transaction: Performance Stock Units — 8,669 contracts (Direct)

Footnotes (2)

1. F1. Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's common stock.
2. F2. Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date.

Key Figures

Performance Stock Units granted: 8,669 PSUs Transaction price per PSU: $0.00 PSUs outstanding after grant: 8,669 PSUs +1 more

4 metrics

Performance Stock Units granted 8,669 PSUs Grant to COO on April 21, 2026

Transaction price per PSU $0.00 Equity compensation grant

PSUs outstanding after grant 8,669 PSUs Held directly by COO following transaction

Underlying common shares 8,669 shares Each PSU equals one share of common stock

Key Terms

Performance Stock Units, contingent right, vesting, commercial launch milestones

4 terms

Performance Stock Units financial

"Each performance stock unit ("PSU") represents a contingent right to receive one share"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

contingent right financial

"represents a contingent right to receive one share of the Issuer's common stock"

vesting financial

"Each PSU will vest upon achievement of certain sales and commercial launch milestones"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

commercial launch milestones financial

"will vest upon achievement of certain sales and commercial launch milestones"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Axsome Therapeutics (AXSM) report in this Form 4 for its COO?

Axsome reported that its Chief Operating Officer, Mark L. Jacobson, received 8,669 Performance Stock Units. These equity awards provide a contingent right to receive Axsome common shares if specified performance milestones and continued service conditions are met over time.

How many Performance Stock Units did the Axsome (AXSM) COO receive?

Mark L. Jacobson received 8,669 Performance Stock Units. Each unit can convert into one share of Axsome common stock if required sales and commercial launch milestones are achieved and he remains employed through the applicable vesting dates.

What are Performance Stock Units in the Axsome (AXSM) COO grant?

Each Axsome Performance Stock Unit represents a contingent right to one share of common stock. The COO’s 8,669 PSUs will only convert into shares if defined sales and commercial launch milestones are reached while he continues serving through those vesting dates.

What conditions determine vesting of the Axsome (AXSM) COO’s PSUs?

The COO’s 8,669 PSUs vest upon achievement of specified sales and commercial launch milestones. Vesting also requires his continued service with Axsome as of each vesting date, making these awards both performance-based and service-based compensation.

Did the Axsome (AXSM) COO pay anything for these 8,669 PSUs?

The Form 4 shows a transaction price of $0.00 per Performance Stock Unit. This indicates the 8,669 PSUs were granted as compensation, not purchased in the open market, and may convert into shares only if the vesting conditions are satisfied.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/23/2026 - 09:02 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jacobson Mark L.

(Last) (First) (Middle)

C/O AXSOME THERAPEUTICS, INC.

ONE WORLD TRADE CENTER, 29TH FLOOR

(Street)

NEW YORK NEW YORK 10007

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Axsome Therapeutics, Inc. [ AXSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Stock Units	(1)	04/21/2026		A		8,669		(2)	(2)	Common Stock	8,669	$0	8,669	D

Explanation of Responses:

1. Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's common stock.

2. Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date.

	/s/ Mark Jacobson	04/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)